Genetic Testing for Hair Loss: What's Actually Worth Testing
Consumer genetic tests promise to reveal your hair loss destiny. The prediction accuracy is modest. But one specific test — SULT1A1 — genuinely changes which treatment you should use first.
A $200 genetic test promising to reveal your hair loss destiny sounds appealing. The field has real science behind it — but the consumer products built on that science are running considerably ahead of what they can actually deliver. Here's where the genetics genuinely matter and where the products are overselling.
01What the genetics of AGA actually look like
Androgenetic alopecia is polygenic — driven by many gene variants, not a single "baldness gene." The most well-characterized is a variant on the androgen receptor gene (AR), inherited through the X chromosome (which is why the "look at your maternal grandfather" advice has some basis). But dozens of other loci contribute, and the genetic architecture is complex enough that no current test can reliably predict your eventual Norwood stage from a saliva sample.
Consumer genetic tests for hair loss have modest predictive accuracy — meaningful at the population level, but not reliable enough to tell any individual man what his specific trajectory will be. A positive result doesn't mean you'll go bald; a negative result doesn't mean you won't.
02The test that does have clinical utility: HairDX's AR variant
The androgen receptor gene variant associated with AGA has better-established evidence than most consumer hair tests. Men who carry the high-risk AR variant tend to have stronger androgen receptor sensitivity in scalp follicles. Some clinicians use this to assess likelihood of finasteride response — the argument being that men with strong AR sensitivity may benefit most from DHT blocking.
03The SULT1A1 enzyme test: more actionable
This isn't a hair loss risk test but a minoxidil response predictor. SULT1A1 is the enzyme that converts minoxidil to its active form in the scalp. Men with low SULT1A1 enzyme activity are significantly more likely to be non-responders to topical minoxidil. A SULT1A1 test gives advance information about whether topical minoxidil will actually work for you — and if you're in the low-activity group, oral minoxidil (which bypasses the enzyme step) is a clear alternative.
The most actionable genetics test in hair loss: SULT1A1 enzyme activity. Not because it predicts loss, but because it predicts drug response — information that changes your treatment choice.
04The bottom line on genetic testing
A positive AR variant result + visible AGA = start treatment. A negative result with visible AGA = still start treatment. The mirror provides better prediction than a saliva kit for the simple question of "am I losing hair?" Where genetics adds real value is in the nuanced question of how to optimize your treatment — particularly the SULT1A1 minoxidil-response question.
Treatment is the same regardless of genetic result
Sesame Care
Telehealth evaluation and prescriptionSame-day telehealth visits for FDA-approved hair-loss prescriptions, from $44.
Sesame connects you with providers for FDA-approved, brand-name medications — no compounded products.
See Sesame Care options Paid linkCare Bare Rx
Prescription hair-loss consultTelehealth hair-loss intake with prescription minoxidil and finasteride options.
See Care Bare Rx options Paid linkAffiliate disclosure. Male Hair Advice may earn a commission when you use the links marked “Paid link,” at no additional cost to you. We only include providers we believe are relevant to the topic, and commercial relationships never change our editorial assessments.